Innoviva Toekomstige groei
Future criteriumcontroles 0/6
Innoviva zal naar verwachting zijn omzet verhogen met 7.1% per jaar.
Belangrijke informatie
n/a
Groei van de winst
n/a
Groei van de winst per aandeel
Pharmaceuticals winstgroei | 23.7% |
Inkomstengroei | 7.1% |
Toekomstig rendement op eigen vermogen | n/a |
Dekking van analisten | Low |
Laatst bijgewerkt | 28 Oct 2024 |
Recente toekomstige groei-updates
Recent updates
Benign Growth For Innoviva, Inc. (NASDAQ:INVA) Underpins Its Share Price
Jul 26Innoviva: Potentially Overvalued
Jun 21Why Innoviva's (NASDAQ:INVA) Shaky Earnings Are Just The Beginning Of Its Problems
May 21Here's Why Innoviva (NASDAQ:INVA) Can Manage Its Debt Responsibly
Feb 05Is Innoviva (NASDAQ:INVA) A Risky Investment?
Nov 04Innoviva (NASDAQ:INVA) Seems To Use Debt Quite Sensibly
Mar 02Innoviva Stock? Not Yet. Short Puts? Definitely.
Sep 19Does Innoviva (NASDAQ:INVA) Have A Healthy Balance Sheet?
Sep 19Does Innoviva (NASDAQ:INVA) Have A Healthy Balance Sheet?
Jun 16Continuing To Avoid Innoviva Inc.
Jun 07We Think Innoviva (NASDAQ:INVA) Can Manage Its Debt With Ease
Mar 04Taking Innoviva Winnings Off The Table, Again
Feb 21Innoviva Inc.: Short Puts Are Compelling
Jan 15Is Innoviva (NASDAQ:INVA) A Risky Investment?
Oct 19Taking Profits In Innoviva Inc.
Oct 16Innoviva reports Q1 results
Apr 28These 4 Measures Indicate That Innoviva (NASDAQ:INVA) Is Using Debt Safely
Mar 30Is Weakness In Innoviva, Inc. (NASDAQ:INVA) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects?
Mar 04Did Innoviva's (NASDAQ:INVA) Share Price Deserve to Gain 36%?
Jan 15These 4 Measures Indicate That Innoviva (NASDAQ:INVA) Is Using Debt Safely
Dec 25Will Weakness in Innoviva, Inc.'s (NASDAQ:INVA) Stock Prove Temporary Given Strong Fundamentals?
Dec 04Innoviva: Only For Short-Term Traders
Nov 04Innoviva reports Q3 results
Oct 28Winst- en omzetgroeiprognoses
Datum | Inkomsten | Inkomsten | Vrije kasstroom | Geldmiddelen uit operationele activiteiten | Gem. Aantal analisten |
---|---|---|---|---|---|
12/31/2026 | 369 | N/A | 123 | 116 | 2 |
12/31/2025 | 341 | N/A | 90 | 93 | 2 |
12/31/2024 | 339 | N/A | N/A | 85 | 2 |
6/30/2024 | 330 | 145 | 158 | 158 | N/A |
3/31/2024 | 312 | 181 | 152 | 152 | N/A |
12/31/2023 | 310 | 180 | 141 | 141 | N/A |
9/30/2023 | 290 | 50 | 116 | 117 | N/A |
6/30/2023 | 290 | 233 | 88 | 88 | N/A |
3/31/2023 | 318 | 233 | 129 | 129 | N/A |
12/31/2022 | 331 | 214 | 202 | 202 | N/A |
9/30/2022 | 373 | 293 | 291 | 291 | N/A |
6/30/2022 | 404 | 99 | 372 | 372 | N/A |
3/31/2022 | 396 | 188 | 378 | 378 | N/A |
12/31/2021 | 392 | 266 | 364 | 364 | N/A |
9/30/2021 | 375 | 309 | 351 | 351 | N/A |
6/30/2021 | 365 | 265 | 329 | 329 | N/A |
3/31/2021 | 344 | 253 | 324 | 324 | N/A |
12/31/2020 | 337 | 224 | 313 | 313 | N/A |
9/30/2020 | 322 | 216 | 295 | 295 | N/A |
6/30/2020 | 299 | 228 | 278 | 278 | N/A |
3/31/2020 | 285 | 189 | 254 | 254 | N/A |
12/31/2019 | 261 | 157 | 257 | 257 | N/A |
9/30/2019 | 265 | 375 | 252 | 252 | N/A |
6/30/2019 | 261 | 382 | 255 | 255 | N/A |
3/31/2019 | 264 | 399 | 250 | 250 | N/A |
12/31/2018 | 261 | 395 | 224 | 224 | N/A |
9/30/2018 | 251 | 190 | 210 | 210 | N/A |
6/30/2018 | 238 | 166 | 193 | 193 | N/A |
3/31/2018 | 229 | 147 | N/A | 164 | N/A |
12/31/2017 | 217 | 134 | N/A | 142 | N/A |
9/30/2017 | 191 | 101 | N/A | 115 | N/A |
6/30/2017 | 176 | 92 | N/A | 92 | N/A |
3/31/2017 | 150 | 72 | N/A | 81 | N/A |
12/31/2016 | 134 | 60 | N/A | 61 | N/A |
9/30/2016 | 113 | 38 | N/A | 47 | N/A |
6/30/2016 | 93 | 19 | N/A | 29 | N/A |
3/31/2016 | 71 | -4 | N/A | 19 | N/A |
12/31/2015 | 54 | -19 | N/A | 10 | N/A |
9/30/2015 | 38 | -39 | N/A | -1 | N/A |
6/30/2015 | 26 | -56 | N/A | -25 | N/A |
3/31/2015 | 16 | -68 | N/A | -82 | N/A |
12/31/2014 | 8 | -74 | N/A | -131 | N/A |
9/30/2014 | 3 | -66 | N/A | -166 | N/A |
6/30/2014 | 2 | -55 | N/A | -186 | N/A |
3/31/2014 | 2 | -9 | N/A | -149 | N/A |
12/31/2013 | 5 | -31 | N/A | -130 | N/A |
Toekomstige groeivoorspellingen analisten
Verdiensten versus spaarpercentage: Er zijn onvoldoende gegevens om te bepalen of de verwachte winstgroei van INVA boven de spaarquote ( 2.6% ) ligt.
Winst versus markt: Er zijn onvoldoende gegevens om te bepalen of de winst van INVA naar verwachting sneller zal groeien dan de markt US
Hoge groeiwinsten: Er zijn onvoldoende gegevens om te bepalen of de winst van INVA naar verwachting de komende 3 jaar aanzienlijk zal groeien.
Omzet versus markt: De omzet van INVA ( 7.1% per jaar) zal naar verwachting langzamer groeien dan de markt US ( 8.8% per jaar).
Hoge groei-inkomsten: De omzet van INVA ( 7.1% per jaar) zal naar verwachting langzamer groeien dan 20% per jaar.
Groeiprognoses winst per aandeel
Toekomstig rendement op eigen vermogen
Toekomstige ROE: Onvoldoende gegevens om te bepalen of het rendement op eigen vermogen van INVA naar verwachting over 3 jaar hoog zal zijn